BioSpace News Archive

Automated volume reduction increases precision and accuracy in rare cell workflows

NetNoggin® releases detailed results from a netnographic-qualitative research study concerning levels of caregiving for patients with Alzheimer’s disease presented at the Alzheimer’s Association International Conference® (AAIC) 2019 Poster Session

She will replace Gordon Naylor, who announced his retirement earlier this year.

Neurotrope Inc. (Nasdaq: NTRP), a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative diseases, including Alzheimer’s disease (AD), today announced that two of the Company’s Scientific Advisory Board members will be participating in a key opinion leader (KOL) call being sponsored by Oppenheimer & Co. Inc.'s Biotechnology team.

The webcast can be accessed live on the Investor Relations section of the Company’s website at http://investors.portola.com.

SOL Global Investments Corp. (“SOL Global” or the “Company”) (CSE:SOL (OTCPK:SOLCF) ) (Frankfurt:9SB) is pleased to announce a US$6.5 million capital infusion in its portfolio company CannCure Investments Inc. (“CannCure”), an investment that is intended to fuel the growth of its position throughout the cannabis markets of Florida, Michigan, and California.

Field’s unique approach is a combination of cutting-edge, FDA-approved techniques to optimize clients’ brain function and performance.

Mindfulness training research done at RMIT University in Melbourne confirms that mindfulness practitioners benefit greatly from the immersive nature of Atmosphaeres’ 360° VR Experiences, particularly if they wish to improve their decentring skills

Cardionics Chief Operating Officer Andy Strandell will continue in his role with Cardionics and is excited about the future growth prospects of the two companies.

Company will hold a teleconference call and live webcast at 4:30 p.m. ET to discuss the results, followed by a question and answer session hosted by Pat Mackin, Chairman, President and Chief Executive Officer of CryoLife, Inc.